JSVRX
Price
$27.66
Change
+$0.19 (+0.69%)
Updated
Jul 3 closing price
Net Assets
1.23B
VSIAX
Price
$86.66
Change
+$0.43 (+0.50%)
Updated
Jul 3 closing price
Net Assets
54.02B
Interact to see
Advertisement

JSVRX vs VSIAX

Header iconJSVRX vs VSIAX Comparison
Open Charts JSVRX vs VSIAXBanner chart's image
JPMorgan Small Cap Value R5
Price$27.66
Change+$0.19 (+0.69%)
VolumeN/A
Net Assets1.23B
Vanguard Small Cap Value Index Admiral
Price$86.66
Change+$0.43 (+0.50%)
VolumeN/A
Net Assets54.02B
JSVRX vs VSIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JSVRX vs. VSIAX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSVRX is a Buy and VSIAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 54B vs. JSVRX (1.23B). VSIAX pays higher dividends than JSVRX: VSIAX (2.11) vs JSVRX (1.06). JSVRX was incepted earlier than VSIAX: JSVRX (19 years) vs VSIAX (14 years). JSVRX (0.86) is less costly to investors than VSIAX (0.07). JSVRX is a more actively managed with annual turnover of: 61.00 vs. VSIAX (16.00). JSVRX has a lower initial minimum investment than VSIAX: JSVRX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 11.67 vs. JSVRX (3.33). VSIAX return over 5 years is better than : 94.16 vs. JSVRX (48.42).
JSVRXVSIAXJSVRX / VSIAX
Total Expense Ratio0.840.071,200%
Annual Report Gross Expense Ratio0.860.071,229%
Fund Existence19 years14 years-
Gain YTD0.8882.04443%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B54B2%
Annual Yield % from dividends1.062.1150%
Returns for 1 year3.3311.6729%
Returns for 3 years12.1734.8835%
Returns for 5 years48.4294.1651%
Returns for 10 years7.6396.538%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TREP0.04N/A
+11.56%
AFINIDA INC
IPXHY14.150.04
+0.28%
Inpex Corp.
BYYLF0.37N/A
N/A
Balyo SA
MEPDF16.25N/A
N/A
Medipal Holdings Corp.
OXBDF4.23N/A
N/A
Oxford Biomedica PLC